# Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease

> **NCT06679374** · PHASE2 · RECRUITING · sponsor: **Vikas Kotagal** · enrollment: 102 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT06679374
- **Lead sponsor:** Vikas Kotagal
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-09
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06679374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06679374, "Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06679374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*